Verastem Oncology Announces Initial Results of RAMP 203 Tria

Verastem Oncology Announces Initial Results of RAMP 203 Trial of Avutometinib and LUMAKRAS™ (sotorasib) in KRAS G12C-Mutant Non-Small Cell Lung Cancer

Verastem Oncology Announces Initial Results of RAMP 203 Trial of Avutometinib and LUMAKRAS™ (sotorasib) in KRAS G12C-Mutant Non-Small Cell Lung Cancer

streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Boston , Massachusetts , United States , Dana Farber Cancer Institute , Dan Paterson , Elisa Buffington , Ryan Porter , Mark Awad , Dan Calkins , Professor Of Medicine At Harvard Medical School , Secura Bio Inc , Exchange Commission , Clinical Research Of The Lowe Center , Drug Administration , Company Annual Report On Form , Chugai Pharmaceutical Co Ltd , Amgen , International Conference On Molecular , Raf And Mek Program , Corporate Communications , Confirmed Responses , Inhibitor Resistant , New Safety Signals Observed , Most Treatment Related Adverse Events Mild , Previously Treated , Inhibitor Ongoing , Molecular Targets , Cancer Therapeutics October , Associate Professor , Harvard Medical School , Clinical Research , Lowe Center , Thoracic Oncology , Breakthrough Therapy , Verastem Oncology , Secura Bio , Annual Report ,